News

Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the ...
Beyond Air granted U.S. patent for treatment of NTM infections using gaseous Nitric Oxide
Beyond Air (NASDAQ:XAIR) said on Thursday that the United States Patent and Trademark Office (USPTO) has issued a U.S. Patent ...
The Manila Times12h
Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision
"Clinicians in critical care are constantly balancing precision and efficiency,” said John Erb, Interim Chief Executive Officer of Nuwellis. "This patent reflects our commitment to supporting them ...
Wearable Devices Secures U.S. Patent for Combined Voice and Gesture Control
Newly allowed patent extends Wearable Devices’ innovative gesture technology into the domain of voice control YOKNEAM ILLIT, ISRAEL, April 23, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the ...
Cardiff Oncology announces second patent for onvansertib combination
Cardiff Oncology (CRDF) announced that the United States Patent and Trademark Office has issued to Cardiff Oncology U.S. patent No. 12,263,173 ...
Palvella Therapeutics granted U.S patent for QTORIN Rapamycin
Palvella Therapeutics (PVLA) announced that the United States Patent and Trademark Office, USPTO, issued patent No. 12,268,673 for claims ...
Goldseiten12d
Battery X Metals Announces Provisional Patent Application with United States Patent ...
Filed Provisional Patents for Battery Lifespan Extension Technology: Battery X Rebalancing Technologies has submitted two provisional U.S. patent applications covering proprietary software and ...
GM Authority4d
GM Files Patent For Power-Operated Seat Armrests
GM has filed a patent application for a power-operated seat armrest system, potentially offering enhanced comfort for ...
TMCnet1d
Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients
The expansion of our intellectual property portfolio strategically positions onvansertib for broader market opportunities and future growth,” said Mark Erlander, Chief Executive Officer of Cardiff ...
JD Supra3d
Improvements in the USPTO’s Processes Between Allowance and Grant Require Quicker Applicant Action
Since April 18, 2023, the United States Patent and Trademark Office (USPTO) has been issuing and publishing patent grants ...
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and ...
TMCnet2d
FluidForm Bio™ Strengthens IP Portfolio with Newly Issued Patent on Key Aspects of its Proprietary FRESH™ Platform
The issuance of this patent marks another key milestone as FluidForm Bio continues to build a strong and defensible IP portfolio and extend its leadership in bioprinted regenerative medicine. The ...